Hospital infection testing kits market seen reaching $7.19 billion by 2030

The hospital-acquired infections testing kits market is projected to grow from $4.79 billion in 2025 to about $7.2 billion by 2030 as hospitals expand infection surveillance and adopt faster diagnostics. North America leads today, while Asia-Pacific is expected to grow fastest.

Why it matters: - Hospital-acquired infection testing kits support faster detection of infections patients pick up in healthcare settings. - The kits are aimed at pathogens such as VRE, MRSA, multi-resistant gram-negative bacilli, norovirus and Clostridium difficile. - Faster testing can help hospitals limit spread, strengthen infection control and improve patient outcomes.

What happened: - The Business Research Company said the global hospital-acquired infections testing kits market was worth $4.79 billion in 2025. - The market is projected to reach $5.19 billion in 2026 and about $7.2 billion by 2030. - The forecast implies an 8.5% compound annual growth rate from 2025 through 2030. - The report was published Aug. 11, 2026. - The company posted a free sample report and a full market report.

The details: - Growth from 2025 to 2026 is tied to infection surveillance programs, antibiotic-resistant pathogens, clinical microbiology lab expansion, stricter infection control protocols and broader access to molecular diagnostics. - Looking ahead to 2030, the market’s rise is linked to early infection detection, hospital safety spending, wider use of rapid testing, demand for automated workflows and advances in molecular diagnostics. - Key market trends include rapid diagnostic test kits, expanded molecular testing for HAIs, automated diagnostic instruments, point-of-care testing and multiplex pathogen detection. - The market covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region during the forecast period.

Between the lines: - More hospitals, urgent care centers, rehabilitation clinics, nursing homes and long-term care facilities increase the need for consistent infection control testing. - The report points to rising surgical volume as another demand driver because surgery creates infection risk and requires post-procedure monitoring. - In the U.S., the American Hospital Association reported hospital counts rising from 6,093 in 2022 to 60,129 in 2023, alongside community hospital admissions increasing from 31,393,318 to 31,967,073. - In Australia, hospitalizations involving surgery increased from 3.0 million in 2022-23 to 3.1 million in 2023-24, according to the Australian Institute of Health and Welfare. - The growth story is not just about more tests. It is also about hospitals moving toward automation and faster turnaround times.

What's next: - The report expects continued adoption of rapid and molecular testing as hospitals push earlier infection detection. - Asia-Pacific’s growth will likely track with healthcare investment, better diagnostics and higher awareness of infection control. - Wider use of automated workflows could reshape how hospitals deploy testing across care settings.

The bottom line: - The hospital-acquired infections testing kits market is expanding on a mix of higher infection-control needs, more surgical care and faster diagnostics, with the biggest opportunity ahead in Asia-Pacific.